COMMUNIQUÉS West-GlobeNewswire
-
FDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL Treatment
01/08/2024 - 22:30 -
La FDA accorde le statut de médicament orphelin à CLLS52 (alemtuzumab) de Cellectis pour le traitement de la LLA
01/08/2024 - 22:30 -
Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
01/08/2024 - 22:30 -
The Pennant Group Announces New $250 Million Credit Facility
01/08/2024 - 22:21 -
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
01/08/2024 - 22:15 -
ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update
01/08/2024 - 22:15 -
CooperCompanies Acquires obp Surgical, Expanding CooperSurgical’s Portfolio of Leading Medical Devices
01/08/2024 - 22:15 -
Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock
01/08/2024 - 22:10 -
Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
01/08/2024 - 22:10 -
Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024
01/08/2024 - 22:10 -
Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance
01/08/2024 - 22:10 -
INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update
01/08/2024 - 22:05 -
Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
01/08/2024 - 22:05 -
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
01/08/2024 - 22:05 -
LeMaitre Q2 2024 Financial Results
01/08/2024 - 22:05 -
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
01/08/2024 - 22:05 -
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
01/08/2024 - 22:05 -
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
01/08/2024 - 22:05 -
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
01/08/2024 - 22:05
Pages